Literature DB >> 218446

Seasonality and the requirements for perpetuation and eradication of viruses in populations.

J A Yorke, N Nathanson, G Pianigiani, J Martin.   

Abstract

Perpetuation of a virus in a population is distinct from the ability to persist in a cell culture or individual host. Parameters which determine perpetuation include: 1) the size of the population; 2) the turnover of the population; 3) the proportion of immunes in the population; 4) the transmissibility of the infection; and 5) the generation time between sequential infections. These parameters may be grouped into two composite factors which most directly affect transmission dynamics and perpetuation: (a) population turnover per generation period, and (b) transmissibility or the fraction of susceptibles infected per existing infection. Perpetuation in small populations usually requires either the ability to persist in individuals or rapid population turnover. Conversely, human viruses which initiate only acute infections require larger populations to persist. Seasonal variation in transmissibility can greatly increase the minimum population size in which persistence is possible, and we argue that the population size of 500,000 for measles persistence (described by Bartlett) is primarily a consequence of seasonal variation. Computer modelling can be used to examine the effect of changes in parameters which determine the seasonal cycle of virus perpetuation and fadeout. Finally, human infections are reviewed to indicate those which have been eradicated (smallpox), are on the threshold of eradication (poliomyelitis), are possibly eradicable (measles), or could be candidates for future efforts (hepatitis A and hepatitis B). In developing a strategy for eradication two points are of great potential utility: first, the seasonal trough should be exploited as a time for effective intervention; and, second, containment efforts should be directed at epidemiologically important population groupings such as schools.

Entities:  

Mesh:

Year:  1979        PMID: 218446     DOI: 10.1093/oxfordjournals.aje.a112666

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  27 in total

1.  Adherence and drug resistance: predictions for therapy outcome.

Authors:  L M Wahl; M A Nowak
Journal:  Proc Biol Sci       Date:  2000-04-22       Impact factor: 5.349

2.  The basic depression ratio of the host: the evolution of host resistance to microparasites.

Authors:  R G Bowers
Journal:  Proc Biol Sci       Date:  2001-02-07       Impact factor: 5.349

3.  Small amplitude, long period outbreaks in seasonally driven epidemics.

Authors:  I B Schwartz
Journal:  J Math Biol       Date:  1992       Impact factor: 2.259

4.  Unusual dynamics of extinction in a simple ecological model.

Authors:  S Sinha; S Parthasarathy
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-20       Impact factor: 11.205

5.  Impact of vaccination on the spatial correlation and persistence of measles dynamics.

Authors:  B M Bolker; B T Grenfell
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

6.  Seroepidemiological study of the transmission of the mumps virus in St. Lucia, West Indies.

Authors:  M J Cox; R M Anderson; D A Bundy; D J Nokes; J M Didier; I Simmons; J St Catherine
Journal:  Epidemiol Infect       Date:  1989-02       Impact factor: 2.451

7.  Changes in the seasonal incidence of measles in Iceland, 1896--1974.

Authors:  A D Cliff; P Haggett
Journal:  J Hyg (Lond)       Date:  1980-12

8.  Infinite subharmonic bifurcation in an SEIR epidemic model.

Authors:  I B Schwartz; H L Smith
Journal:  J Math Biol       Date:  1983       Impact factor: 2.259

9.  Measles eradication policies.

Authors:  N D Noah
Journal:  Br Med J (Clin Res Ed)       Date:  1982-04-03

10.  Epidemiology of measles in Taiwan: dynamics of transmission and timeliness of reporting during an epidemic in 1988-9.

Authors:  M S Lee; C C King; C J Chen; S Y Yang; M S Ho
Journal:  Epidemiol Infect       Date:  1995-04       Impact factor: 2.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.